Download PDF
Int J Sports Med 2012; 33(06): 421-425
DOI: 10.1055/s-0032-1301892
Physiology & Biochemistry
© Georg Thieme Verlag KG Stuttgart · New York

Effect of Aspirin Dose on Gastrointestinal Permeability

G. P. Lambert
1   Creighton University, Exercise Science, Omaha, United States
,
A. Schmidt
1   Creighton University, Exercise Science, Omaha, United States
,
K. Schwarzkopf
1   Creighton University, Exercise Science, Omaha, United States
,
S. Lanspa
2   Creighton University, Medicine, Omaha, United States
› Author Affiliations
Further Information

Publication History



accepted after revision 23 December 2011

Publication Date:
29 February 2012 (online)

Also available at
    Permissions and Reprints

Abstract

The primary purpose of this study was to determine the aspirin dose that increases gastrointestinal (GI) permeability. A pilot study was also conducted to determine whether the menstrual cycle affects GI permeability. Both portions of the study involved 4 experimental conditions. For the aspirin portion, 8 subjects ingested 0 mg, 325 mg, 650 mg, or 975 mg of aspirin the night before and the morning of an experiment. For the menstrual cycle pilot study, 5 female subjects with regular menstrual cycles were tested for GI permeability on the same day each week for 4 weeks. GI permeability was assessed by the urinary excretion of ingested probes. Sucrose (5 g) was used to determine gastroduodenal permeability. Lactulose (5 g) and rhamnose (2 g) were used to assess small intestinal permeability via the lactulose-to-rhamnose urinary excretion ratio (L/R). The data indicated that the menstrual cycle had no effect on GI permeability. In contrast, gastroduodenal permeability was significantly (P <0.008) increased following a dose of 650 mg aspirin and small intestinal permeability (L/R) was significantly (P <0.008) increased following a dose of 975 mg aspirin. These results suggest healthy individuals should be cautious even with acute aspirin use as it may result in GI barrier dysfunction.

Key words

gut - menstrual cycle - athletes
 

  • References

  • 1 Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-1581
    CrossrefPubMedSearch in Google Scholar
  • 2 Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292-1297
    CrossrefPubMedSearch in Google Scholar
  • 3 Bjarnason I, Zanelli G, Prouse P, Williams P, Gumpel MJ, Levi AJ. Effect of non-steroidal anti-inflammatory drugs on the human small intestine. Drugs 1986; 32 (Suppl. 01) 35-41
    CrossrefPubMedSearch in Google Scholar
  • 4 Bovo P, Paola Brunori M, Di Francesco V, Frulloni L, Montesi G, Cavallini G. The mentrual cycle has no effect on gastrointestinal transit time. Evaluation by means of the lactulose H2 breath test. Ital J Gastroenterol 1992; 24: 449-451
    PubMedSearch in Google Scholar
  • 5 Brock-Utne J, Gaffin S, Wells M, Gathiram P, Sohar E, James M, Morrell D, Norman R. Endotoxemia in exhausted runners after a long-distance race. S Afr Med J 1988; 73: 533-536
    PubMedSearch in Google Scholar
  • 6 Fred HL. The 100-mile run: preparation, performance, and recovery: A case report. Am J Sports Med 1981; 9: 258-261
    CrossrefPubMedSearch in Google Scholar
  • 7 Garnett WR. GI effects of OTC analgesics: implications for product selection. J Am Pharm Assoc 1996; NS36: 565-572
    PubMedSearch in Google Scholar
  • 8 Gisolfi CV. Is the GI system built for exercise?. News Physiol Sci 2000; 15: 114-119
    PubMedSearch in Google Scholar
  • 9 Gisolfi CV, Mora F. The Hot Brain. Cambridge: The MIT Press; 2000. 158.
    Search in Google Scholar
  • 10 Harriss DJ, Atkinson G. Update – Ethical standards in sport and exercise science research. Int J Sports Med 2011; 32: 819-821
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Jackson LM, Hawkey CJ. NSAIDs and the GI tract-potential hazards and benefits. Apoptosis 1999; 4: 397-402
    CrossrefPubMedSearch in Google Scholar
  • 12 Jeukendrup AE, Vet-Joop K, Sturk A, Stegen JH, Senden J, Saris WH, Wagenmakers AJ. Relationship between gastro-intestinal complaints and endotoxemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci (Lond) 2000; 98: 47-55
    CrossrefPubMedSearch in Google Scholar
  • 13 Lambert GP. Intestinal barrier dysfunction, endotoxemia and gastrointestinal symptoms: The ‘canary in the coal mine’ during exercise-heat stress?. In: Marino FE. (ed.) Medicine and Sport Science. Vol. 53. Thermoregulation and Human Performance: Physiological and Biological Aspects Basel: Karger; 2008: 61-73
    Search in Google Scholar
  • 14 Lambert GP. Role of gastrointestinal permeability in exertional heatstroke. Exerc Sport Sci Rev 2004; 32: 185-190
    PubMedSearch in Google Scholar
  • 15 Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci 2009; 87: E101-E108
    CrossrefPubMedSearch in Google Scholar
  • 16 Lambert GP, Boylan MW, Laventure J-P, Bull AJ, Lanspa SJ. Effect of aspirin and ibuprofen on GI permeability during exercise. Int J Sports Med 2007; 28: 722-726
    Thieme ConnectPubMedSearch in Google Scholar
  • 17 Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104: 1619-1626
    PubMedSearch in Google Scholar
  • 18 Mones J, Carrio I, Calabuig R, Estorch M, Sainz S, Berna L, Vilardell F. Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers. Eur J Nucl Med 1993; 20: 600-602
    PubMedSearch in Google Scholar
  • 19 Payan DG, Shearn MA. Nonsteroidal anti-inflammatory drugs; Nonopioid analgesics; Drugs used in gout. In: Katzung BG. ed. Basic and Clinical Pharmacology. 4th edition Norwalk: Appleton & Lange; 1989: 431-450
    Search in Google Scholar
  • 20 Ryan AJ, Chang R-T, Gisolfi CV. Gastrointestinal permeability following aspirin intake and prolonged running. Med Sci Sports Exerc 1996; 28: 698-705
    PubMedSearch in Google Scholar
  • 21 Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Scott D, Gumpel MJ, Bjarnason I. Intestinal permeability and inflammation in patients on NSAIDS. Gut 1998; 43: 506-511
    CrossrefPubMedSearch in Google Scholar
  • 22 Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, Macpherson AJS, Bjarnson I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroent 1995; 30: 289-299
    CrossrefPubMedSearch in Google Scholar
  • 23 Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, Rafi S, Roseth A, Foster R, Price AB, Wrigglesworth JM, Bjarnason I. Uncoupling of intestinal mitochondiral oxidative phosphorylation and inhibition of cyclooxygenase are requried for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000; 15: 639-650
    PubMedSearch in Google Scholar
  • 24 Tomlinson J, Blikslager A. Role of nonsteroidal anti-inflammatory drugs in gastrointestinal tract injury and repair. J Am Vet Med Assoc 2003; 222: 946-951
    CrossrefPubMedSearch in Google Scholar